• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Anisoles

Introduction to (3-methoxyphenyl)methylhydrazine (CAS No. 85293-12-5)

(3-methoxyphenyl)methylhydrazine, with the CAS number 85293-12-5, is a significant compound in the field of organic chemistry and pharmaceutical research. This compound, featuring a methoxy group on the phenyl ring and a hydrazine moiety, has garnered attention due to its versatile applications in synthetic chemistry and potential roles in drug development.

The structure of (3-methoxyphenyl)methylhydrazine consists of a benzene ring substituted with a methoxy group at the 3-position and an N-methylhydrazine side chain. This particular arrangement imparts unique chemical properties that make it valuable in various chemical transformations. The presence of both electron-donating and electron-withdrawing groups on the aromatic ring allows for selective reactions, making it a useful intermediate in the synthesis of more complex molecules.

In recent years, research into (3-methoxyphenyl)methylhydrazine has expanded significantly, particularly in the context of medicinal chemistry. Its hydrazine group is known to participate in various functionalization reactions, including condensation reactions with carbonyl compounds to form hydrazones. These hydrazones have been explored as precursors for more complex pharmacophores, contributing to the development of new therapeutic agents.

One of the most intriguing aspects of (3-methoxyphenyl)methylhydrazine is its potential as a building block for biologically active compounds. Studies have demonstrated its utility in constructing heterocyclic scaffolds, which are prevalent in many drugs. For instance, derivatives of this compound have been investigated for their antimicrobial and anti-inflammatory properties. The methoxy group on the phenyl ring can be further modified through various chemical pathways, allowing for the creation of diverse molecular structures with tailored biological activities.

The synthesis of (3-methoxyphenyl)methylhydrazine typically involves multi-step organic reactions, starting from commercially available aromatic precursors. The process often requires careful control of reaction conditions to ensure high yield and purity. Advances in synthetic methodologies have enabled more efficient and scalable production methods, making this compound more accessible for research purposes.

In the realm of computational chemistry, (3-methoxyphenyl)methylhydrazine has been studied to understand its electronic properties and reactivity. Molecular modeling techniques have provided insights into how the compound interacts with other molecules, which is crucial for designing effective drugs. These computational studies help predict potential side effects and optimize drug candidates before they enter clinical trials.

The pharmaceutical industry has shown particular interest in (3-methoxyphenyl)methylhydrazine due to its potential as a scaffold for novel therapeutics. Researchers are exploring its derivatives as candidates for treating various diseases, including neurological disorders and cancer. The hydrazine moiety's ability to form stable bonds with other functional groups makes it a valuable component in drug design.

Ethical considerations are also important when researching compounds like (3-methoxyphenyl)methylhydrazine. Ensuring that synthetic pathways are environmentally sustainable and that research is conducted responsibly are key priorities. Collaborative efforts between academia and industry are essential to drive innovation while maintaining high ethical standards.

The future of (3-methoxyphenyl)methylhydrazine research looks promising, with ongoing studies aimed at uncovering new applications and improving synthetic methods. As our understanding of organic chemistry evolves, so too will the ways in which this compound is utilized. Continued investment in research and development will be crucial to realizing its full potential in pharmaceuticals and beyond.

• 140-69-2([(4-methoxyphenyl)methyl]hydrazine)
• 135-54-6((2,5-dimethoxyphenyl)methylhydrazine)
• 887595-99-5(Hydrazine,[[3-(4-methoxyphenoxy)phenyl]methyl]-)
• 804429-21-8(5-(hydrazinylmethyl)-2-methoxyphenol)
• 85293-11-4((3-phenoxyphenyl)methylhydrazine)
• 887596-61-4(3,5-Dimethoxy-benzyl-hydrazine)
• 887594-18-5(Hydrazine,[(4-phenoxyphenyl)methyl]-)
• 135-85-3((3,4-Dimethoxybenzyl)hydrazine)
• 2011-48-5([(4-methoxyphenyl)methyl]hydrazine hydrochloride)
• 194242-26-7(4-Pyrimidineacetaldehyde,a-(hydroxymethylene)-)